相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial
Maria Vittoria Dieci et al.
CLINICAL CANCER RESEARCH (2022)
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management
Matt Lechner et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer
Brenton A. Maisel et al.
CANCERS (2022)
Impact of HPV status on immune responses in head and neck squamous cell carcinoma
Hannan A. Qureshi et al.
ORAL ONCOLOGY (2022)
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival
Ziena Abdulrahman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
Cindy Simoens et al.
BMC INFECTIOUS DISEASES (2022)
Sex and cancer immunotherapy: Current understanding and challenges
Laura Pala et al.
CANCER CELL (2022)
The spectrum of sex differences in cancer
Joshua B. Rubin
TRENDS IN CANCER (2022)
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Anna Tosi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Is There a Role for Sex Hormone Receptors in Head-and-neck Cancer? Links with HPV Infection and Prognosis
Clariano Pires de Oliveira Neto et al.
ANTICANCER RESEARCH (2021)
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Fabio Conforti et al.
CLINICAL CANCER RESEARCH (2021)
Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer A Systematic Review and Meta-analysis
Razan Masarwy et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2021)
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Robert L. Ferris et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy
Ajaz A. Bhat et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas
Farah Succaria et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
Miroslaw Snietura et al.
PATHOBIOLOGY (2020)
Human T cells interacting with HNSCC-derived mesenchymal stromal cells acquire tissue-resident memory like properties
Alessio Mazzoni et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
Steven F. Powell et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The impact of sex and gender on immunotherapy outcomes
Sabra L. Klein et al.
BIOLOGY OF SEX DIFFERENCES (2020)
Sex differences in the association between tumor growth and T cell response in a melanoma mouse model
Panshak P. Dakup et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
Annelisa M. Cornel et al.
CANCERS (2020)
Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers
Attia M. Elbehi et al.
ORAL ONCOLOGY (2020)
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab
Maria Grazia Narducci et al.
FRONTIERS IN IMMUNOLOGY (2020)
Resident Memory T Cells and Their Effect on Cancer
Daniel J. Craig et al.
VACCINES (2020)
The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma
Marij J. P. Welters et al.
FRONTIERS IN ONCOLOGY (2020)
CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
Stephanie Corgnac et al.
CELL REPORTS MEDICINE (2020)
A prognostic gene expression signature for oropharyngeal squamous cell carcinoma
Xinyi Liu et al.
EBIOMEDICINE (2020)
Validation of Gene Profiles for Analysis of Regional Lymphatic Metastases in Head and Neck Squamous Cell Carcinoma
Zhenrong Hu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103+ immune cell abundance
B. Solomon et al.
ANNALS OF ONCOLOGY (2019)
Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
Valerie Cristina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer A Phase 2 Clinical Trial
Erminia Massarelli et al.
JAMA ONCOLOGY (2019)
A Current Update on Human Papillomavirus-Associated Head and Neck Cancers
Ebenezer Tumban
VIRUSES-BASEL (2019)
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Ezra E. W. Cohen et al.
LANCET (2019)
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
Colt A. Egelston et al.
JCI INSIGHT (2019)
CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naive Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment
Jarem Edwards et al.
CLINICAL CANCER RESEARCH (2018)
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Fabio Conforti et al.
LANCET ONCOLOGY (2018)
Double positivity for HPV-DNA/p16(ink4a) is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients
Marisa Mena et al.
ORAL ONCOLOGY (2018)
The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?
Paolo Boscolo-Rizzo et al.
PLOS ONE (2018)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment
Elisa Peranzoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Thomas Duhen et al.
NATURE COMMUNICATIONS (2018)
Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8+ T Cells in Head and Neck Cancer
Krishna et al.
CANCER RESEARCH (2018)
Treatment-naive HPV plus head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
Steven F. Gameiro et al.
ONCOIMMUNOLOGY (2018)
Resident memory T cells, critical components in tumor immunology
Fathia Mami-Chouaib et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
Nicolas A. Giraldo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study
Lea Schroeder et al.
EUROPEAN JOURNAL OF CANCER (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
CD8+ T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer
Liam Masterson et al.
EUROPEAN JOURNAL OF CANCER (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
CD8+ CD103+ Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
Faycal Djenidi et al.
JOURNAL OF IMMUNOLOGY (2015)
Innate vs. Adaptive: PD-L1-mediated immune resistance by melanoma
Sneha Berry et al.
ONCOIMMUNOLOGY (2015)
Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
Simona Partlova et al.
ONCOIMMUNOLOGY (2015)
Programmed death ligand-1 expression in non-small cell lung cancer
Vamsidhar Velcheti et al.
LABORATORY INVESTIGATION (2014)
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cecile Badoual et al.
CANCER RESEARCH (2013)
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
Sofia Lyford-Pike et al.
CANCER RESEARCH (2013)
Correlation of Cellular Immunity With Human Papillomavirus 16 Status and Outcome in Patients With Advanced Oropharyngeal Cancer
Derrick Wansom et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2010)
Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma
Dominik Pretscher et al.
BMC CANCER (2009)
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation
Se-Heon Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
High macrophage infiltration along the tumor front correlates with improved survival in colon cancer
Johan Forssell et al.
CLINICAL CANCER RESEARCH (2007)
Histopathological predictors of occult lymph node metastases in supraglottic squamous cell carcinomas
A Ozdek et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2000)
分享论文
